Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

Go back to Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

Organon & Co. (OGN) PT Lowered to $19 at Goldman Sachs

February 14, 2025 11:58 AM EST

Goldman Sachs analyst Chris Shibutani lowered the price target on Organon & Co. (NYSE: OGN) to $19.00 (from $20.00) while maintaining a Neutral rating.

The analyst comments "OGN shares outperformed (+11% vs. +1% SPX on the day) in the context of 4Q24 results that were generally in line with expectations overall. FY2025 guidance - that actually came in slightly... More